BioHealth News Archive

HIV Cure Program Releases Initial Clinical Trial Data | American Gene Technologies

HIV Cure Program Releases Initial Clinical Trial Data | American Gene Technologies

ROCKVILLE, MD, July 15, 2021 /Globe Newswire/ -- American Gene Technologies (AGT) announced today that the Data and Safety Monitoring Board (DSMB) voted unanimously…

Read More
Emergent BioSolutions wins extension on smallpox vaccine deal – Baltimore Business Journal

Emergent BioSolutions wins extension on smallpox vaccine deal – Baltimore Business Journal

The extension follows a tumultuous time for the Gaithersburg company, making it unclear if the government would proceed with deals as normal.   {iframe}https://www.bizjournals.com/baltimore/news/2021/07/21/emergent-biolsolutions-wins-smallpox-vaccine-deal.html{/iframe}

Read More

Covid vaccine maker BioNTech buys Gaithersburg manufacturing facility – Washington Business Journal

The German firm hopes to expand its cancer treatments with the purchase. Image: BioNTech is buying a Gaithersburg manufacturing facility on Clopper Road from…

Read More
Immunomic’s Academic Collaborator Dr. John Sampson Recognized as “World Expert” in Glioblastoma as Part of Glioblastoma Awareness Day | Business Wire

Immunomic’s Academic Collaborator Dr. John Sampson Recognized as “World Expert” in Glioblastoma as Part of Glioblastoma Awareness Day | Business Wire

ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms, announced today that its’…

Read More
BioNTech to Acquire Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, MD · BioBuzz

BioNTech to Acquire Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, MD · BioBuzz

MAINZ, Germany & SANTA MONICA, Calif.–(BUSINESS WIRE)–BioNTech SE (Nasdaq: BNTX, “BioNTech”) and Kite, a Gilead Company (Nasdaq: GILD, “Kite”) today announced the two companies…

Read More

Alexandria Plans 200K SF Lab Building To Kick Off Huge Rockville Project

Montgomery County is set to consider plans for the first phase of a five-building life sciences project in Rockville.  An affiliate of life sciences…

Read More

Science Magazine: ARPA-H: Accelerating biomedical breakthroughs | The White House

The biomedical research ecosystem has delivered advances that not long ago would have been inconceivable, exemplified by highly effective COVID-19 vaccines developed by global…

Read More
Game Changers | VT Corporate Research Center

Game Changers | VT Corporate Research Center

Come join the Virginia Tech Corporate Research Center for Game Changer Week! Game Changer Week, set for August 23-27, 2021 will bring together industry…

Read More
Ascentage Pharma Establishes Cooperative R&D Agreement (CRADA) with the National Cancer Institute for Clinical Development of Ascentage Pharma’s Drug Compound pelcitoclax | BioSpace

Ascentage Pharma Establishes Cooperative R&D Agreement (CRADA) with the National Cancer Institute for Clinical Development of Ascentage Pharma’s Drug Compound pelcitoclax | BioSpace

SUZHOU, China, and ROCKVILLE, Md., July 19, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers,…

Read More
Join Our Celebration | American Gene Technologies

Join Our Celebration | American Gene Technologies

The Data Safety and Monitoring Board has met and evaluated the safety data from the first participant treated with AGT103-T, our HIV-cure drug candidate.…

Read More
Maryland-based Novavax’s effort to vaccinate the world, from zero to not quite warp speed: ‘This takes time and expertise’ – Baltimore Sun

Maryland-based Novavax’s effort to vaccinate the world, from zero to not quite warp speed: ‘This takes time and expertise’ – Baltimore Sun

On a sweltering June morning, Novavax CEO and COVID vaccine maker Stanley Erck stood on a stage unmasked and did something that would have…

Read More
Citybiz Interview with Ronald Piervincenzi, CEO of U.S. Pharmacopeia | citybiz

Citybiz Interview with Ronald Piervincenzi, CEO of U.S. Pharmacopeia | citybiz

Ronald T. Piervincenzi, Ph.D., has served as Chief Executive Officer of the U.S. Pharmacopeia (USP) since February 2014. USP is an independent, nonprofit, scientific…

Read More
Exclusive: White House taps Maryland professor for tech role

Exclusive: White House taps Maryland professor for tech role

President Biden will nominate Laurie E. Locascio to lead the federal agency in charge of promoting innovation and technology, the National Institute of Standards…

Read More
GSK to build $549m biotech hub in Stevenage, UK

GSK to build $549m biotech hub in Stevenage, UK

GlaxoSmithKline (GSK) has plans to open an approximately $549m (£400m) biotechnology campus in Stevenage, UK, which would possibly create up to 5,000 skilled jobs…

Read More

With $1.27B raised, DC stays on record-setting pace for venture capital funding in 2021 – Technical.ly DC

Venture capital totals for D.C. area companies got off to a strong start in 2021, and they’re continuing to rise with a new record…

Read More